Involved with important cellular or gene functions and implicated with many kinds of cancers, piRNAs, or piwi-interacting RNAs, are of small non-coding RNA with around 19-33 nt in length. Given a small non-coding RNA molecule, can we predict whether it is of piRNA according to its sequence information alone? Furthermore, there are two types of piRNA: one has the function of instructing target mRNA deadenylation, and the other does not. Can we discriminate one from the other? With the avalanche of RNA sequences emerging in the postgenomic age, it is urgent to address the two problems for both basic research and drug development. Unfortunately, to the best of our knowledge, so far no computational methods whatsoever could be used to deal with the second problem, let alone deal with the two problems together. Here, by incorporating the physicochemical properties of nucleotides into the pseudo K-tuple nucleotide composition (PseKNC), we proposed a powerful predictor called 2L-piRNA. It is a two-layer ensemble classifier, in which the first layer is for identifying whether a query RNA molecule is piRNA or non-piRNA, and the second layer for identifying whether a piRNA is with or without the function of instructing target mRNA deadenylation. Rigorous cross-validations have indicated that the success rates achieved by the proposed predictor are quite high. For the convenience of most biologists and drug development scientists, the web server for 2L-piRNA has been established at http://bioinformatics. hitsz.edu.cn/2L-piRNA/, by which users can easily get their desired results without the need to go through the mathematical details.
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INTRODUCTION
With a length of around 19-33 nt, piRNAs (piwi-interacting RNAs) distinctly belong to the largest class of small non-coding RNA molecules in animal cells. [1] [2] [3] [4] They are involved with many cellular or gene functions including the transposon silencing, specific protein translation, gene expression regulation, and the formation and maintenance of germ cells. [5] [6] [7] Moreover, many studies (see, e.g., Mei et al., 8 Cheng et al., 9 Moyano and Stefani, 10 and Hashim et al. 11 ) have shown that piRNAs have been implicated with many kinds of cancers. Therefore, knowledge about piRNAs and their functions is very important for drug development, as well as for RNA biology and many other relevant areas.
Given an RNA molecule, can we identify whether it belongs to piRNA? Lee et al. 12 and Nishibu et al. 13 had developed some experimental methods to address this problem, greatly stimulating the development of this area. But purely using experimental methods alone to do the sequence analyses is not only inefficient and expensive, but also insensitive for many cases (e.g., it is difficult to get sufficient quantity of samples for observation). Facing the explosive growth of RNA sequences in the postgenomic age, to make the piRNA analysis in a more efficient way, as well as in a faster pace and at a deeper level, we could not help but resort to the computational approach.
Actually, several computational methods have been proposed for classifying piRNA from non-piRNA sequences. For instance, by combining the k-mer scheme and support vector machine (SVM), Zhang et al. 14 proposed a model called piRNApredictor. Three years later, Wang et al. 15 proposed a different model for predicting piRNAs by using the transposon interaction and SVM. Recently, two more papers were published for identifying piRNAs. One was authored by Luo et al., 16 who considered the physicochemical properties of RNA sequences, and the other was authored by Li et al., 17 who used the powerful ensemble approach. Both methods were quite powerful, reaching the state-of-the-art performance.
It is instructive to point out, however, that there are two types of piRNA in the real world. One has the function of instructing target mRNA deadenylation 18 and the other does not. But none of the aforementioned methods has the function to distinguish these two types.
The present study was initiated in an attempt to fill in this empty area by developing a new predictor that not only can be used to identify piRNAs, but also can be used to identify their functional types.
RESULTS AND DISCUSSION
Listed in Table 1 Table 1 , we can clearly see the following: (1) for the first-layer prediction, the new predictor 2L-piRNA is superior to the existing state-of-the-art methods in both accuracy (Acc) and Matthews correlation coefficient (MCC), the two most important metrics; the former reflects the overall accuracy of a predictor, and the latter reflects its stability; (2) it is slightly better or comparable with the existing state-of-the-art methods in Sn (sensitivity) and Sp (specificity); and (3) for the second-layer prediction, 2L-piRNA is overwhelmingly better because the existing state-ofthe-art methods simply did not have the function to yield any results at this step. Accordingly, the significance of the newly proposed predictor is self-evident.
To further show the advantage of the current 2L-piRNA in using the ensemble classifier approach, we adopted the graphic analysis because it is particularly useful for studying complicated biological systems, as demonstrated by a series of previous studies in many different fields (see, e.g., Jiang et al., 19 Chou and Forsén, 20 Zhou and Deng, 21 Chou, 22 Althaus et al., 23, 24 Wu et al., 25 Chou et al., 26 Zhou, 27 and Zhou et al. 28 ). Shown in Figure 1 is the graph of receiver operating characteristic (ROC). 29, 30 As we can see from the figure, the area under the ROC curve (AUC) for the ensemble classifier is remarkably larger than any of the individual ones in both the first-layer case ( Figure 1A ) and second-layer case ( Figure 1B ), once again demonstrating the merit of 2L-piRNA via the intuitive graphical approach.
Conclusions
It is anticipated that the 2L-piRNA will become a very useful highthroughput tool in genome analysis and drug development, particularly in those areas involved with non-coding RNAs.
MATERIALS AND METHODS

Benchmark Dataset
According to Chou's five-step rule 31 for developing a really useful statistical predictor, the first important thing is to construct or select a reliable benchmark dataset. In literature the benchmark dataset usually consists of a training dataset and a testing dataset: the former is for the usage of training a model, whereas the latter is for testing the model. But as elucidated in a comprehensive review, 32 there is no need to artificially separate a benchmark dataset into the aforementioned two parts if the prediction model is examined by the jackknife test or subsampling (K-fold) cross-validation because the outcome thus obtained is actually from a combination of many different independent dataset tests. Thus, the benchmark datasets S for the current study can be formulated as
where S À is the negative subset that contains the non-piRNA samples only, W is the symbol for union in the set theory, S + is the subset that contains the piRNA samples only, S + inst is the sub-subset that contains piRNA samples having the function of instructing target mRNA deadenylation, 18 whereas S + nonÀinst is the sub-subset without such function.
The concrete procedures to construct the benchmark dataset of Equation 1 are as follows: (1) The piRNA sequences were taken from piRBase; 33 (2) collected for S + inst are only those samples that were annotated with piRNA having the function of instructing target mRNA deadenylation; (3) collected for S + nonÀinst are only those samples that were annotated with piRNA without the function of instructing target mRNA deadenylation; (4) the corresponding non-piRNA sequences for the negative subset S À were taken from Bu et al.; 34 (5) the CD-HIT software 3 with the cutoff threshold 0.8 was used to remove the redundancy for each of the aforementioned subsets; and (6) to minimize the negative effect caused by the skewed benchmark dataset, 35-38 the random sampling method was applied to balance out each of the subsets with its counterpart. The final benchmark dataset obtained by strictly following the above procedures contains 2,836 samples, of which 709 belong to S + inst , 709 to S + nonÀinst , and 1,418 to S À . The new method presented in this paper. The existing state-of-the-art method proposed by Luo et al. Figure 2 is the sequence length distribution of the samples in the benchmark dataset; their detailed sequences and the relevant codes are given in the Supplemental Information.
Shown in
Pseudo K-Tuple Nucleotide Composition
With a good benchmark dataset, the next thing we need to consider is how to formulate the samples therein. Actually, this is one of the most challenging problems in computational biology. This is because all the existing machine learning algorithms were designed to handle the discrete models or vectors only. 39 But a biological sequence expressed by a vector may completely miss its sequence order or pattern, 40 so as to limit the prediction quality. The pseudo amino acid composition (PseAAC) was proposed to deal with such a dilemma. [40] [41] [42] [43] [44] [45] Ever since the concept of PseAAC was introduced, it has been rapidly and widely used in nearly all the areas of computational proteomics (see, e.g., Du et al., 45 Lin and Lapointe, 46 Chou, 47 Khan et al., 48 and Meher et al. 49 and a long list of references cited in these papers). Inspired by the great successes of using PseAAC to represent protein-peptide sequences, the PseKNC (pseudo K-tuple nucleotide composition) was introduced to represent DNA/RNA sequences. 50-54 Likewise, since its introduction, PseKNC has also been increasingly applied in many areas of genome analysis.
37,55-68
For an RNA sample with L nucleotide, its sequence expression is generally given by
where N i˛f A ðadenineÞ; C ðcytosineÞ; G ðguanineÞ; U ðuracilÞ g
denotes the nucleotide at the i-th sequence position, and˛is the a symbol in the set theory meaning "member of." According to a recent review paper, 69 the general form of PseKNC for R of Equation 2 can be formulated as
where the components f u ðu = 1; 2; /Þ and Z is an integer; their values will depend on how the desired features are extracted from the RNA sample; and T is the transposing operator to a matrix or vector.
In this study, we take
where f
KÀtuple u is the u-th component of the K-tuple nucleotide composition for the RNA sample sequence, and
In Equation 6, the correlation function or coupling factor is given by
where m is the number of physicochemical properties considered, whereas H x ðN i N i + 1 /N i + KÀ1Þ Þ is the numerical value of the x-th physicochemical property for the K-mer N i N i + 1 /N i + KÀ1 in the RNA sequence, and so forth.
In this study, we consider pseudo dinucleotide composition. Thus, we can substitute K = 2 into Equations 5, 6, and 7. Also, we used the values of the following six RNA dimer's physicochemical properties: rise, roll, shift, slide, tilt, and twist (Table 2) . Thus, we can substitute m = 6 as well as Rise ( The greater the area under the ROC curve (AUC) value is, the better the performance will be.
, and so forth into Equation 7 to get the coupling factors.
Note that before substituting them into Equation 7, all the original values in Table 2 were subjected to a standard conversion, 41 as described by the following equations:
where the symbol "< >" means taking the average of the quantity therein over 16 different dinucleotides. The converted values obtained by Equation 8 will have a zero mean value over the 16 different dinucleotides and will remain unchanged if going through the same conversion procedure again. Listed in Table 3 are the corresponding values obtained via the standard conversion of Equation 8 from those of Table 2 .
Operation Engine
Below, let us consider the third step of the five-step rule, 31 i.e., what kind of algorithms should be used to operate the training and predicting.
Support Vector Machine
Being widely used in many different areas of computational biology (see, e.g., Feng et al. 70 Han et al., 71 Liu et al., 72 Qumar et al., 73 Kiu et al., 74 Liu et al., 75, 76 Rahimi et al., 77 and Chen et al. 78 ), SVM is a powerful algorithm in cluster analysis. Its basic idea has been elaborated in the aforementioned papers, and hence there is no need to repeat it here. For those who are interested in knowing more about SVM, refer to the previous papers 79, 80 or a monograph. 81 In this study, we used the Scikit-learn 82 as the implementation of the LIBSVM 83 with the radial basis function (RBF) kernel.
Two-Layer Classification Framework
Inspired by the recent study, 76 we constructed a two-layer classification framework as done in Chou and Shen, [84] [85] [86] Wang et al., 87 Xiao et al., [88] [89] [90] and Shen and Chou. [91] [92] [93] The SVM model in the first-layer classifier was trained with S of Equation 1, serving to predict a query RNA sample as of piRNA or non-piRNA; the SVM model in the second layer was trained with S + of Equation 1 to further identify whether the predicted piRNA sample is with the function of instructing target mRNA deadenylation. Shown in Figure 3 is a flowchart to illustrate how the two-layer classifier is working.
Ensemble Learning
As we can see from Equations 5 and 6, the RNA sample defined by the PseKNC approach in this study contains three uncertain parameters: K, l, and w. In this study, the ranges considered for these parameters are In other words, K may be 1, 2, 3, 4, 5, and 6; l may be 1, 5, 9, 13, 17, and 19; w may be 0.1, 0.3, 0.5, 0.7, and 0.9. Accordingly, there are a total of 5 Â 6 Â 5 = 150 individual classifiers for each layer.
Suppose each of these individual classifiers is expressed by CðiÞ ði = 1; 2; /; 150Þ, their ensemble classifier C E can be formulated as
where the symbol c denotes the fusing operator. 32 The ensemble predictor formed by fusing an array of individual predictors via a voting system can yield much better prediction quality, as demonstrated by a series of previous studies including signal peptide prediction, 86 Unfortunately, if all of the 150 classifiers in Equation 10 were directly used to form an ensemble predictor by the voting approach, it would be not only computationally inefficient, but also might reduce the success rate because of too much noise. One of the effective approaches is to select some key classifiers from them. To realize this, let us introduce the concept of "complementing degree" between two individual classifiers, C(i) and C(j), or their "mutually strengthening degree," D(i,j), as defined below:
Dði; jÞ = 1 À 1 2m
C t ði; jÞ ð0%Dði; jÞ%1Þ ;
where m represents the number of training samples, and C t ði; jÞ = & p t ðiÞ + p t ðjÞ; if both f ail 0; otherwise :
In Equation 12, p t (i) denotes the probability or output when applying the classifier C(i) on the t-th sample, p t (j) the corresponding output for C(j), and "both fail" means that both predicted results are incorrect.
By means of Equations 11 and 12, all of the 150 classifiers in each layer were clustered with the AP (affinity propagation) clustering algorithm 101 using the default parameters. Four clusters were thus obtained for each of the two layers. Subsequently, the classifiers in the four cluster centers were selected as the representative classifiers, respectively, that have the highest complementing/strengthening degrees, as illustrated by the flowchart in Figure 4 . Suppose the four 
Listed in Table 4 are the detailed values of their parameters for the first and second layers, respectively. Thus, instead of Equation 10, the final ensemble classifier should be formulated as 
Note that different from the ensemble classifiers formed in Chou and Shen 102-105 and Qiu et al., 106 ,107 the voting weighted factors V w were included during the fusion process for each layer, and their optimal values can be easily derived by optimizing success rates during the validation process as shown in Table 4 (Voting Weighted Factor V w column).
The predictor developed via the above procedures is called 2L-piRNA, where 2L represents the two-layer ensemble classifier and piRNA represents the piwi-interacting RNA and its function.
Prediction Quality Measurement
How to measure the prediction quality is one of the five indispensable steps 31 in developing a new prediction method for a biological system. It consists of two issues: What scales should be used to measure the predictor's quality? And what test method should be adopted to score them? Below, let us address the two problems one by one.
Formulation of Measurement Scales
The following metrics were widely used in the literature to measure the prediction quality from four different aspects: (1) Acc that was used for checking the overall accuracy of a predictor, (2) MCC for its stability, (3) Sn for its sensitivity, and (4) Sp for its specificity. 108 Unfortunately, the four metrics' original formulations copied directly from mathematical books are difficult to understand for most biologists due to lack of intuitiveness. Fortunately, by using the scales defined by Chou 109 in studying signal peptides, Xu et al. 110 and Chen et al. 55 had successfully converted them into a set of intuitive equations that are much easier for most biologists to understand, as given below:
where N + represents the total number of the positive samples investigated, whereas N + À is the number of the positive samples incorrectly predicted to be negative, and N À is the total number of the negative samples investigated, whereas N À + is the number of the negative samples incorrectly predicted to be positive. Based on the definition of Equation 15 , the meanings of Sn, Sp, Acc, and MCC have become much more intuitive and easier to understand, as discussed and used in a series of recent studies in various biological areas (see, e.g., Jia et ).
It should be pointed out, however, that for the multi-label systems (see, e.g., Xiao et al., 90 Qiu et al., 118 Xiao et al., 124 Chou et al., 125 Lin et al., 126 and Cheng et al. 127 ), a much more sophisticated set of scales is needed as elaborated by Chou. 
Cross-Validation
There are three different cross-validation methods 129 that are widely used in literature: (1) jackknife test, (2) subsampling (or K-fold crossvalidation) test, and (3) independent dataset test. Of these three, however, the jackknife is the least arbitrary that can always yield a unique outcome for a given benchmark dataset, as elaborated by Chou 31 and widely recognized and increasingly adopted by researchers to analyze the quality of various predictors (see, e.g., Kabir and Hayat, 64 Kumar et al., 73 Chen et al., 78 Ali and Hayat, 130 Khan et al., 131 Mondal and Pai, 132 Dehzangi et al., 133 Ahmad et al., 134 Ju et al., 135 and Behbahani et al. 136 ). In this study, however, to reduce the computational time, we adopted the 5-fold cross-validation method for each layer in 2L-piRNA, as done by many investigators with SVM as the prediction engine. For each layer, the benchmark dataset was divided into five subsets; for each run, four subsets were used as the training set, and the remaining one was used as the test set to evaluate the performance. This process was repeated five times until each subset was used as a test set once. To do this, we first randomly divided the benchmark datasets in Equation 1 into five subsets with approximately the same size.
where W, X, and B represent the symbols for union, intersection, and empty set in the set theory, 95, 137 respectively, and
with & S
where S + 1 denotes the number of samples (or cardinalities) in S + 1 , and so forth.
Then, each of the five sub-benchmark datasets was singled out one by one and tested by the model trained with the remaining four subbenchmark datasets. The cross-validation process was repeated five times, with their average as the final outcome. In other words, during the process of 5-fold cross-validation, both the training dataset and testing dataset were actually open, and each sub-benchmark dataset was in turn moved between the two. The 5-fold cross-validation test can exclude the "memory" effect, just like conducting five different independent dataset tests.
Web Server and User Guide
In Chou's five-step rule 31 for developing a useful predictor, the last one is to establish a user-friendly web server. This not only represents the future direction for developing any computational methods, 138 but is also particularly important for most experimental scientists working in drug development. 39 Accordingly, as done in a series of recent studies, 63, 66, 67, 107, 112, 117, 127, [139] [140] [141] the web server for 2L-piRNA has been established as well. Moreover, to maximize users' convenience, a step-by-step guide is provided below.
Step 1. Open the web server at http://bioinformatics.hitsz.edu.cn/ 2L-piRNA/ and you will see its top page as shown in Figure 5 . Click on the Read Me button to see a brief introduction about the server and the caveat when using it.
Step 2. You can either type or copy/paste the query RNA sequence into the input box. You can also directly upload your input data via the Browse button. The input sequence should be in the FASTA format. For the examples of sequences in the FASTA format, click the Example button right above the input box.
Step 3. Click on the Submit button to see the predicted results. For example, if you use the four query RNA sequences in the Example The optimal parameters were K = 2, l = 1, w = 0.1, C = 2 7 , g = 2.
b
The optimal parameters were K = 2, l = 5, w = 0.3, C = 2 15 , g = 2
À1
. c
The optimal parameters were K = 3, l = 5, w = 0.1, C = 2 13 , g = 2
. d The optimal parameters were K = 4, l = 1, w = 0.3, C = 2 13 , g = 2 À1 .
e The optimal parameters were K = 2, l = 1, w = 0.9, C = 2 13 , g = 2. f The optimal parameters were K = 3, l = 5, w = 0.1, C = 2 9 , g = 2.
g The optimal parameters were K = 6, l = 5, w = 0.7, C = 2 7 , g = 2 3 . h The optimal parameters were K = 6, l = 17, w = 0.9, C = 2 11 , g = 2 3 .
www.moleculartherapy.org window as the input, you will see on your computer screen that the first and second query sequences are of non-piRNA. The third one is of piRNA with the function for instructing target mRNAs deadenylation. The fourth one is of piRNA, but without that function. All these predicted results are fully consistent with the experimental observations as reported in Gou et al. 18 
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